Fortitude Family Office’s Anika Therapeutics ANIK Stock Holding History

Fortitude Family Office’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263	Buy	+18	New	+$267	﹤0.01%	2078

Other funds holding ANIK

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Fortitude Family Office's ANIK Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 18 shares worth $263. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings.

17 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

Fortitude Family Office held 18 shares of Anika Therapeutics worth $263 as of Q2 2026.
Anika Therapeutics was a new Fortitude Family Office position in Q2 2026.
Anika Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2078 holding.
17 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.